Ilan Rosen - 22 May 2026 Form 4 Insider Report for CERAGON NETWORKS LTD (CRNT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 May 2026, 08:11:39 UTC
Prior SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Netta Cohen on behalf of Oppenheimer Israel, as Attorney-in-fact

Key filing fact

Ilan Rosen filed Form 4 for CERAGON NETWORKS LTD (CRNT) on 26 May 2026.

Key facts

  • This page summarizes Ilan Rosen's Form 4 filing for CERAGON NETWORKS LTD (CRNT).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 26 May 2026, 08:11.

Change

  • Previous filing in this sequence was filed on 18 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001538257 Primary reporting owner

Rosen Ilan

Relationship
Director
Address
C/O MAGICJACK VOCALTEC LTD., 12 BENNY GOAN STREET, BUILDING 2B, NETANYA
Signature
/s/ Netta Cohen on behalf of Oppenheimer Israel, as Attorney-in-fact
Signature date
26 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRNT transaction

Ordinary Shares

Award

Transaction value
Shares
+9,770
Change %
+16%
Price
$0.000000*
Shares after
71,270
Date
22 May 2026
Ownership
Direct
Footnotes
F1
CRNT transaction

Ordinary Shares

Award

Transaction value
Shares
+22,120
Change %
+31%
Price
$0.000000*
Shares after
93,390
Date
23 May 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRNT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+19,540
Change %
Price
$0.000000*
Shares after
19,540
Date
22 May 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
19,540
Exercise price
$2.79
Footnotes
F3
CRNT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+44,240
Change %
Price
$0.000000*
Shares after
44,240
Date
23 May 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
44,240
Exercise price
$2.80
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Ceragon Networks Ltd. (the "Company"). The RSUs were fully vested upon grant and were automatically settled in ordinary shares on the grant date 05/22/2026.

Footnote F2

The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Ceragon Networks Ltd. (the "Company"). The RSUs were fully vested upon grant and were automatically settled in ordinary shares on the grant date 05/23/2026.

Footnote F3

The Reporting Person was granted stock options to purchase ordinary shares of Ceragon Networks Ltd. (the "Company"). The options were fully vested and immediately exercisable on the grant date 05/22/2026

Footnote F4

The Reporting Person was granted stock options to purchase ordinary shares of Ceragon Networks Ltd. (the "Company"). The options were fully vested and immediately exercisable on the grant date 05/23/2026

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .